Investing

Today's Market Winners and Losers

Source: Wikimedia Creative Commons, JohnnyMrNinja
The stock market is down Tuesday, with the Dow Jones Industrial Average down 0.60%, the Nasdaq down 0.44% and the S&P 500 down 0.56%. Today’s winners both include mergers, while today’s loser sank due to a major competitor securing an exclusive licensing deal.

Here are Tuesday’s market winners and loser.

Biggest Winners

Shares of Medicis Pharmaceutical Corp. (NYSE: MRX) are up 37.90% to $43.52 on trading volume of 19.4 million shares. Valeant Pharmaceuticals International Inc. (NYSE: VRX) has agreed to buy Medicis for $2.6 billion. Before Tuesday, the 52-week high was $40.10.

Shares of Heckmann Corp. (NYSE: HEK) are up 20.45% to $3.24 on trading volume of 5.7 million shares. The company announced its intentions to buy Power Fuels for $380.5 million in cash, debt and stock. The 52-week high is $7.05.

Biggest Loser

Shares of Netflix Inc. (NASDAQ: NFLX) are down 10.92% to $53.20 on trading volume of 4.1 million shares. Rival Amazon.com Inc. (NASDAQ: AMZN) has signed a content deal to add EPIX movies to Prime streaming. The 52-week low is $52.81.

Samuel Weigley

Follow him on Twitter: SWeigley

Essential Tips for Investing: Sponsored

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.